Araceli Sepulveda Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 23 El Yunque, Urb. El Bosque, Coamo, PR 00769 Phone: 787-528-6857 |
Zuleyka Marie Rodriguez-colon, SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 124 Calle Jose I Quinton, Coamo, PR 00769 Phone: 787-930-4679 |
Alma L Rivera Speech-Language Pathologist Medicare: Medicare Enrolled Practice Location: Bo Pasto Sector San Luis Carr 14 Ramal 5556, Coamo, PR 00769 Phone: 787-508-2224 |
Miss Emily Yanel Mercado Colon, MS - SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: Carr. 153 Km 12.4 Las Flores, Coamo, PR 00769 Phone: 787-901-0381 |
Miss Paula Febus-davila, SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: Las Flores, Callejon Bravo St., Coamo, PR 00769 Phone: 787-825-4108 |
Susana Montanez-gonzalez Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: Calle Jose I. Quinton #47, Coamo, PR 00769 Phone: 787-929-1513 Fax: 787-803-4359 |
Vilma E Rivera Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: Hw Santaella #66, Coamo, PR 00769 Phone: 787-238-7018 |
News Archive
The effects of tumour-targeting drugs in mice are significantly enhanced by PCI Biotech's light-activated delivery system, a new study shows. Researchers say this dual therapy approach could be employed to increase the effect and lower the side effects of anti-cancer drugs in humans.
Glenn Wylie, DPhil, associate director of the Rocco Ortenzio Neuroimaging Center at Kessler Foundation, has received a $300,000 sub-award from the National Institutes of Health for a collaborative study with the University of Alabama at Birmingham.
Air pollution is made up of both gaseous and particulate matter. Each year almost two million people die as a direct result of air pollution with many more experiencing impaired lung function, developing lung diseases such as asthma and chronic obstructive pulmonary disease.
OriGene Technologies, Inc., a gene-centric life sciences company, announces the acquisition of Blue Heron Biotechnology, a pioneer in the gene synthesis business since 1999.
› Verified 3 days ago